Speaker illustration

Doctor Tatsuya Yamaji

Kanonji (Japan)

Examination of the acute efficacy and safety about aggressive use of tolvaptan for early rising after admission in super-elder patients with congestive heart failure.

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chronic heart failure e-posters


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb